Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Signatures to Be Filed for California Drug Price Referendum

Sharon Bernstein  |  October 30, 2015

SACRAMENTO, Calif. (Reuters)—Backers of a referendum aimed at reducing the cost of prescription drugs in California said Wednesday that they had gathered more than enough signatures to place their measure on the November 2016 ballot in the most populous U.S. state.

The measure by the AIDS Healthcare Foundation would require the state to pay no more for prescription medications than does the federal Veterans Administration, which negotiates aggressively with drug companies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“If prices are lower, the burden on taxpayers is going to be lower,” said Michael Weinstein, the organization’s longtime president. “It’s also going to trickle down to the copays and costs of what people pay for pharmaceuticals.”

The Los Angeles-based organization, which provides services to AIDS and HIV patients and is involved in public health advocacy, has collected nearly 550,000 signatures from California voters to place the measure on the ballot, more than the 366,000 valid signatures needed, Weinstein said in an exclusive interview with Reuters.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The group plans to file the signatures with the state on Nov. 2.

The measure is expected to generate fierce opposition from the pharmaceutical industry, which already has a war chest of about $10 million in a campaign account set up to fight it.

According to the state’s campaign finance website, donations include $5.7 million from Johnson & Johnson and $2.8 million from Bristol-Myers Squibb Co.

“While this ballot measure may look simple, the changes being proposed will have adverse consequences for Californians,” said Kathy Fairbanks, spokeswoman for the campaign against the measure.

“If it goes forward we will be preparing a campaign to educate voters in California about its negative consequences.”

Weinstein said the organization had tried for years to persuade the California legislature to adopt laws that would control spiraling pharmaceutical costs in the state, to no avail.

He predicted that anger over high prices for prescription drugs would lead to strong support for the measure. Prices paid by the state would be tied to those negotiated by the Veterans Administration, because the federal agency has negotiated rates for the drugs that it buys that are 20 to 25% lower than most other customers pay.

The organization is also seeking to qualify a similar measure for the ballot in Ohio. Three years ago, it successfully backed a ballot measure requiring adult film actors in Los Angeles to use condoms. The organization is currently backing a statewide version of that measure.

Share: 

Filed under:Drug UpdatesLegislation & AdvocacyProfessional Topics Tagged with:costsdrugLegislationpharmaceutical company

Related Articles

    Every Vote Counts

    September 11, 2020

    It came down to the toss of a coin. David Yancey represented the Newport News district in the Virginia House of Delegates beginning in 2011. In 2017, he had a challenger. Shelly Simonds, a member of the local school board, decided to run for the privilege of representing the 94th District. The final tally: 11,608…

    Five Ways to Get Involved in the American College of Rheumatology (ACR) Simple Tasks Campaign

    April 6, 2012

    Last September, the ACR launched its first public relations campaign, called Simple Tasks. Here are five ways you can become a part of this important campaign.

    Bending, Not Breaking

    August 16, 2019

    “And of course, I am not telling you to do it. That would be illegal.” As a general rule, I try not to instruct my patients to break the law. My business model depends on repeat customers, so placing a patient at risk of getting arrested—even if that risk is remote—doesn’t seem like a good…

    HIV Infection: What Rheumatologists Need to Know

    HIV Infection: What Rheumatologists Need to Know

    June 15, 2015

    It has been nearly 35 years since the original descriptions of what now is recognized as AIDS (the acquired immune deficiency syndrome), an advanced form of infection secondary to the human immunodeficiency virus (HIV). The epidemic of HIV infection remains the singular most dramatic epidemic of our generation and will likely remain with us for…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences